A study on the medications prescribed to children suffering from cancer for better cancer treatment in the future
Not Applicable
- Conditions
- Health Condition 1: null- Paediatric Cancers
- Registration Number
- CTRI/2018/01/011263
- Lead Sponsor
- Dr Girish Chinnaswamy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either gender and age between 3months -15 years(19) diagnosed with cancer and has received treatment for atleast 6 weeks duration.
2. Legally Acceptable Representative(LAR)of the patient willing to give voluntary informed consent.
3. Patient between the age 7-12 years willing to give voluntary verbal assent.
4.Patient above the age of 12 years willing to give voluntary informed assent.
Exclusion Criteria
Any other medical condition, which in the opinion of the investigator precludes the
inclusion of the participant.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the prescription pattern of drugs used in treatment of paediatric cancer patientsTimepoint: February 2018 - December 2019
- Secondary Outcome Measures
Name Time Method To assess the off-label use of anti-cancer drugs used in paediatric oncology.Off label use will be analyzed using the following information about the anti-cancer drugs prescribed â?? <br/ ><br>1.Dose <br/ ><br>2.Dosage form <br/ ><br>3.Frequency of administration <br/ ><br>4.Indication of the drug <br/ ><br>5.Route of administration <br/ ><br>Timepoint: February 2018 - December 2019 <br/ ><br>